Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keenan Wells

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs|March 14, 2017
Phage Therapy: Future InquiriesSijia Wu, Elisabeth Zachary, Keenan Wells, et al.
BMJ Open|July 28, 2025
Mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH): protocol for a prospective, randomised, open-label, blinded-endpoint phase IIb trialKailash Krishnan, Emma Grace, Lisa Woodhouse, et al.
Clinical Neurology and Neurosurgery|February 14, 2026
Baseline characteristics of patients recruited to the mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH) trialKailash Krishnan, Emma Grace, Lisa Woodhouse, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs|March 14, 2017
Phage Therapy: Future InquiriesSijia Wu, Elisabeth Zachary, Keenan Wells, et al.
BMJ Open|July 28, 2025
Mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH): protocol for a prospective, randomised, open-label, blinded-endpoint phase IIb trialKailash Krishnan, Emma Grace, Lisa Woodhouse, et al.
Clinical Neurology and Neurosurgery|February 14, 2026
Baseline characteristics of patients recruited to the mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH) trialKailash Krishnan, Emma Grace, Lisa Woodhouse, et al.
Pageof 1